Board of Directors


Sanford J. Hillsberg, esq.

  • Chairman, Co-Founder, Nacuity Pharmaceuticals, Inc.
  • Managing Partner Troy Gould, Harvard Law Cum Laude
  • Chairman, Galena BioPharma
  • Co-Founder/Director Medco Research

Isaac Blech

  • Vice-Chairman of the Board, Co-Founder, Nacuity Pharmaceuticals, Inc.
  • Vice-Chairman, Cerecor, Inc., Medgenics, Inc., Centrexion Corporation, X4 Pharma, WaveGuide, Aridis, Sapience Therapeutics, Inc., Regenovation, SpendSmart, and root9B Technologies
  • Co-Founder, Celgene Corporation, Genetic Systems Corporation, Icos Corporation, Nova Pharmaceuticals Corporation and PathoGenesis Corporation, etc.; combined value > $100 billion

Gerald D. Cagle, Ph.D.

  • Over 20 years at Alcon, including serving as Global Head R&D, Chief Scientific Officer and VP Regulatory Affairs
  • Holds more than 20 issued patents and has authored numerous peer reviewed scientific articles
  • Director of Aerie, Clearside Biomedical, GrayBug Drug Delivery and FFB-CRI

Richard Chin, M.D., M.A.

  • CEO and Director, KindredBio, Inc.
  • Former CEO and Former President, Oxigene
  • Former CEO, OneWorld Health
  • Has overseen development of many new drug applications including Lucentis
  • Adjunct professor UC San Francisco

Halden Conner

  • CEO, President, Co-Founder, Nacuity Pharmaceuticals, Inc.
  • Director, Private Access, Inc.
  • Co-founder, Protom International
  • Former Alcon Board Member

David Wohlberg, esq.

  • Co-Founder, Nacuity Pharmaceuticals, Inc.
  • Former President, ImmunoCellular Therapeutics, Inc.
  • Managing Principal, Birtcher Anderson